These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30020258)

  • 1. Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
    Ben-Eli H; Solomon A
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):411-416. PubMed ID: 30020258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.
    Kam KW; Chen LJ; Wat N; Young AL
    Ocul Immunol Inflamm; 2017 Oct; 25(5):663-677. PubMed ID: 27192186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.
    Castillo M; Scott NW; Mustafa MZ; Mustafa MS; Azuara-Blanco A
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009566. PubMed ID: 26028608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.
    Fujishima H; Ohashi Y; Takamura E
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):476-81. PubMed ID: 25163405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis.
    Bielory L; Lien KW; Bigelsen S
    Drugs; 2005; 65(2):215-28. PubMed ID: 15631542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
    Mah FS; Rosenwasser LJ; Townsend WD; Greiner JV; Bensch G
    Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.
    Figus M; Fogagnolo P; Lazzeri S; Capizzi F; Romagnoli M; Canovetti A; Iester M; Ferreras A; Rossetti L; Nardi M
    Eur J Ophthalmol; 2010; 20(5):811-8. PubMed ID: 20383847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular comfort and drying effects of three topical antihistamine/mast cell stabilizers in adults with allergic conjunctivitis: a randomized, double-masked crossover study.
    Torkildsen GL; Ousler GW; Gomes P
    Clin Ther; 2008 Jul; 30(7):1264-71. PubMed ID: 18691985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.
    McLaurin EB; Marsico NP; Ackerman SL; Ciolino JB; Williams JM; Villanueva L; Hollander DA
    Adv Ther; 2014 Oct; 31(10):1059-71. PubMed ID: 25260889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis.
    Ono SJ; Lane K
    Drug Des Devel Ther; 2011 Feb; 5():77-84. PubMed ID: 21340041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular allergy treatment comparisons: azelastine and olopatadine.
    Bielory L; Buddiga P; Bigelson S
    Curr Allergy Asthma Rep; 2004 Jul; 4(4):320-5. PubMed ID: 15175148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.
    Katelaris CH; Ciprandi G; Missotten L; Turner FD; Bertin D; Berdeaux G;
    Clin Ther; 2002 Oct; 24(10):1561-75. PubMed ID: 12462286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcaftadine: a topical antihistamine for use in allergic conjunctivitis.
    Namdar R; Valdez C
    Drugs Today (Barc); 2011 Dec; 47(12):883-90. PubMed ID: 22348913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulators for conjunctivitis.
    Pacharn P; Vichyanond P
    Curr Opin Allergy Clin Immunol; 2013 Oct; 13(5):550-7. PubMed ID: 23974685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.
    Gonzalez-Estrada A; Reddy K; Dimov V; Eidelman F
    Expert Opin Pharmacother; 2017 Aug; 18(11):1137-1143. PubMed ID: 28656804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis.
    Ayyappanavar S; Sridhar S; Kumar K; Jayanthi CR; Gangasagara SB; Rathod BLS; Preethi B; Mittal P
    Indian J Ophthalmol; 2021 Feb; 69(2):257-261. PubMed ID: 33463568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of topical antihistamines in an animal model of early phase allergic conjunctivitis.
    Sanchis-Merino ME; Montero JA; Ruiz-Moreno JM; Rodriguez AE; Pastor S
    Exp Eye Res; 2008 May; 86(5):791-7. PubMed ID: 18378229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.